Clinical trial
Double-Blind, Placebo Controlled Randomized Study of Co-Administering Testosterone With PDE5 Inhibitors in Patients Non-Responders to PDE5 Inhibitors Alone
NCT00244023 is registered in ClinicalTrials.gov with SELARL du Dr Jacques BUVAT as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Placebo Controlled Randomized Study of Co-Administering Testosterone With PDE5 Inhibitors in Patients Non-Responders to PDE5 Inhibitors Alone
- Lead sponsor
- SELARL du Dr Jacques BUVAT
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2005
- Completion date
- July 31, 2007
- Enrollment
- 173 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.